Clinical Trial Update: Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral venetoclax in adults with relapsed or refractory Waldenström macroglobulinemia and lymphoplasmacytic lymphoma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoplasmacytic Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma | Phase 2 | Status: RECRUITING